#BMK Experience Shared
0+
Attendees Representing Vaccine Manufacturers, Institutes, Regulators
0+
Companies From India, China, Africa, Brazil, Russia And More!
0+
Speakers Sharing Their Expertise
0+
In-Person Networking Hours
0+
Case Studies


The Concept
Home to the second-largest pharmaceutical market in the world, Japan has poised itself as one of the most lucrative biotech hubs in Asia and worldwide. Over recent years, the Japanese biologics market has opened its doors to both foreign companies entering the Japanese market and companies investing abroad. Japan’s biopharma sector has had a keen eye on alliance opportunities in markets beyond its borders and although the nature of its sector is a cautious one, its move towards transparency and international collaboration provides bountiful opportunities that both the domestic and international players stand to benefit from.
The key drivers driving the growth of the biologics industry in Japan are the formation of numerous bio-clusters that house world-class universities with cutting-edge technologies and know-how, excellence in the implementation of automation technology, huge amounts of financial support for orphan drugs, tax breaks, and subsidies for new entrants in the market, the government’s push for the creation of technologies and services, and development of the supporting infrastructure. Factors hindering the growth of the biopharmaceutical industry mainly are from the bioprocessing side including high manufacturing complexities expensive purification processes and other challenges across the bioprocessing value chain. Meanwhile trials and roll outs for COVID vaccines and antivirals will position Japan at the forefront of crucial life-saving initiatives.Agenda of the BMK 2022 is built around success stories from korea’s biopharmas as well as the technical expertise from international biopharmas and big pharmas, presentations on the latest manufacturing technologies such as single-use and end-to-end continuous processing for biologics, today’s challenges and opportunities in biomanufacturing, advances in upstream process development, cost-optimization strategies in downstream processing, analytical characterization strategies, advanced bioprocessing technique and antibody production, fill & finish innovation to streamline the operations amongst other crucial themes.
Agenda At A Glance - Biologics World Japan
Challenges and Opportunities in Japanese Bioprocessing
Cell Line Development & Engineering
Clinical Trials for Japan
Upstream Challenges and Strategies
Downstream Processing, Recovery & Purification
Fill & Finish
Integration of Continuous Processes
Analytics& Quality
Agenda At A Glance - BioLogistics World Japan
Supply Chain Risk & Resilience for Biopharmas
Biologics Cold Chain Support
Planning and Building GDP Compliant Distribution Hubs
Supply Chain Digitisation
Active and Passive Packaging
Ultra Cold Storage for Biologics and Vaccines
Last Mile Delivery for Temperature-Sensitive Drugs
2022 Sponsors
Tickets On Sale, Catch The Limited Special Deal Now To SAVE BIG!
Standard Price- END USER
Standard Price - Vendor
Featured Content
1
Thought Leadership
Present your expertise to the key vaccines stakeholders from developing economies through a variety of available speaking packages.
2
Exhibit
Join the exhibition, and build an impressive presence among your potential clients.
3
Branding
Emphasize on your messages by promoting your brand alongside exhibition and thought leadership.
4
Networking
Engage with and build lasting connections that matter the most to your business.
5
Lead Generation
Gain exclusive access to contacts of high-profile attendees through intimate networking opportunities.